Parra Mario A, Garcia Adolfo M, Ibanez Agustin
University of Strathclyde, Glasgow, United Kingdom.
Instituto de Neurociencia Cognitiva y Traslacional (INCyT), Buenos Aires, Argentina.
Alzheimers Dement. 2021 Dec;17 Suppl 8:e055106. doi: 10.1002/alz.055106.
LAC-CD has recently reported that challenges faced by LAC countries are very similar to those experienced by HIC, and that regional networks will be needed to bridge gaps. ReDLat is a US-LAC multi-partner consortium aimed at expanding dementia research in LAC. The UK-Latin America Brain Connectivity Research Network (UL-BCRN) focuses on developing new affordable EEG-based biomarkers for dementia. The Language and Brain Health Network (LBHN) integrate international multidisciplinary efforts to reveal linguistic markers of neurodegenerative diseases.
ReDLat is collecting genomic, neuroimaging, clinical, cognitive, and socioeconomic data from a first-in-class cohort anchored in six LAC (Argentina, Chile, Colombia, Brazil, Mexico, and Peru) and will compare these to US data (> 4200 participants, including 2100 controls, 1050 AD patients, and 1050 FTD patients). The 5-year project will develop innovative, harmonized, and cross-nation approaches on two of the most prevalent neurodegenerative diseases, Alzheimer's disease (AD) and Frontotemporal Dementia (FTD). The UL-BCRN currently links seven EEG labs from Colombia, Argentina, Chile, Brazil and the UK. The network's vision is to forge strong relationships between labs through which new methodologies, EEG plus multidimensional datasets, and experience will be developed and shared. The LBHN will analyze speech samples from massive AD, FTD, and control cohorts across LAC, Spain, and the US. This effort aims to identify low-cost disease-specific markers in diverse Latino and English-speaking patients.
ReDLat will aims to reveal unique risk factors for AD and FTD in LAC compared to US populations. Data collection strategies have been adapted to face the challenges brought by the COVID-19 pandemic. The UL-BCRN has now standardised recording protocols across LAC and UK labs and is collecting data from longitudinal cohorts of patients at risk of dementia relying on novel culture-free cognitive paradigms. Preliminary LBHN data shows that, automated speech analyses can identify Latinos with AD and FTD, with good generalization across socio-biological profiles, dialects, and languages.
By broadening our understanding of dementia phenotypes, risk factors, and affordable diagnostic approaches in LAC, adding new evidence on variability across HIC and LMIC, the above networks will contribute unique knowledge that will help enhance future global dementia strategies.
拉丁美洲和加勒比地区痴呆症协作组(LAC-CD)最近报告称,拉丁美洲和加勒比地区国家面临的挑战与高收入国家(HIC)所经历的挑战非常相似,并且需要区域网络来弥合差距。拉丁美洲痴呆症研究协作组(ReDLat)是一个由美国和拉丁美洲及加勒比地区多方合作的联盟,旨在扩大拉丁美洲和加勒比地区的痴呆症研究。英国-拉丁美洲脑连接性研究网络(UL-BCRN)专注于开发新的、经济实惠的基于脑电图的痴呆症生物标志物。语言与脑健康网络(LBHN)整合国际多学科努力,以揭示神经退行性疾病的语言标志物。
ReDLat正在从一个一流队列中收集基因组、神经影像学、临床、认知和社会经济数据,该队列以六个拉丁美洲和加勒比地区国家(阿根廷、智利、哥伦比亚、巴西、墨西哥和秘鲁)为基础,并将这些数据与美国的数据进行比较(超过4200名参与者,包括2100名对照、1050名阿尔茨海默病患者和1050名额颞叶痴呆患者)。这个为期5年的项目将针对两种最常见的神经退行性疾病——阿尔茨海默病(AD)和额颞叶痴呆(FTD),开发创新、统一且跨国的方法。UL-BCRN目前连接了来自哥伦比亚、阿根廷、智利、巴西和英国的七个脑电图实验室。该网络的愿景是在各实验室之间建立紧密的关系,通过这些关系开发并共享新方法、脑电图加多维数据集以及经验。LBHN将分析来自拉丁美洲和加勒比地区、西班牙及美国的大量阿尔茨海默病、额颞叶痴呆患者及对照人群的语音样本。这项工作旨在识别不同拉丁裔和说英语患者中低成本的疾病特异性标志物。
与美国人群相比,ReDLat旨在揭示拉丁美洲和加勒比地区阿尔茨海默病和额颞叶痴呆的独特风险因素。数据收集策略已进行调整,以应对新冠疫情带来的挑战。UL-BCRN现已在拉丁美洲和加勒比地区及英国的实验室中标准化了记录协议,并正在依靠新型无文化认知范式,从有痴呆症风险的患者纵向队列中收集数据。LBHN的初步数据表明,自动语音分析可以识别患有阿尔茨海默病和额颞叶痴呆的拉丁裔患者,并且在社会生物学特征、方言和语言方面具有良好的普遍性。
通过拓宽我们对拉丁美洲和加勒比地区痴呆症表型、风险因素及经济实惠的诊断方法的理解,增加关于高收入国家和低收入及中等收入国家之间变异性的新证据,上述网络将贡献独特的知识,这将有助于加强未来的全球痴呆症战略。